Prasinezumab
Prasinezumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Prasinezumab is under investigation in clinical trial NCT03100149 (A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease).
| Trade Name | Prasinezumab |
| Generic | Prasinezumab |
| Prasinezumab Other Names | Prasinezumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Prasinezumab
